Sienna Cancer Diagnostics (ASX:SDX) to merge with BARD1 Life Sciences (ASX:BD1)

" First Graphene (ASX:FGR) reflects on December quarter

First Graphene (FGR) has rounded out the December quarter with a review of its leadership changes, financial position and latest activities.
Two decades of trade: The S&P/ASX Index Series turns 20

" What’s in store for the All Ords in 2021?

It’s been a tumultuous year for Australia’s benchmark indices.
Medibio (ASX:MEB) - Managing Director, Claude Solitario - The Market Herald

" Medibio (ASX:MEB) device suffers regulatory hurdle

Medibio (MEB) has suffered a regulatory hurdle after the U.S. Food and Drug Administration (FDA) deflected a product approval.
Cann Global (ASX:CGB): Disrupting the lucrative Australian cannabis market

" Cann Global (ASX:CGB) investors convert debt into equity

The latest investment from Cann Global’s (CGB) noteholders will see the company walk into the new year debt-free.
Crown Resorts (ASX:CWN) - Chair, Helen Coonan - The Market Herald

" Crown Resorts (ASX:CWN) appoints Financial Crimes Officer amid Bergin inquiry

Crown Resorts (CWN) has appointed Steven Blackburn as its Chief Compliance and Financial Crimes officer after its Barangaroo casino opening was delayed.
Westpac (ASX:WBC) - CEO, Peter King - The Market Herald

" Westpac (ASX:WBC) to sell insurance branch to Allianz

Banking giant Westpac (WBC) is set to sell its insurance arm to Allianz for $725 million.
Australia tables economic growth for the first time since March

" Australia tables economic growth for the first time since March

Australia has tabled economic growth for the first time since March as coronavirus restrictions begin to ease across the nation.
Strategic Elements (ASX:SOR) hits development milestone with battery ink

" Strategic Elements (ASX:SOR) hits development milestone with battery ink

Venture builder Strategic Elements (SOR) is one step closer to producing self-charging batteries after it successfully scaled up its battery ink.
Telix Pharmaceuticals (ASX:TLX) - CEO, Dr Christian Behrenbruch - The Market Herald

" Telix Pharmaceuticals (ASX:TLX) eyes TheraPharma buy

Telix Pharmaceuticals (TLX) is set to buy Swiss-German biotech TheraPharm for €10.2 million (around A$16.5 million) upfront.
Telstra Corporation (ASX:TLS) - CEO, Andrew Penn - The Market Herald

" Telstra (ASX:TLS) faces $50M fine after “unconscionable” sales to Indigenous consumers

The consumer watchdog will take Telstra (TLS) to court after the telco admitted to “unconscionable conduct” while selling phone plans to Indigenous consumers.